About Chadi El Saleeby, MD

Chadi El Saleeby, MD, is a pediatric hospitalist and ID specialist with research interests in Respiratory Syncytial Virus (RSV), clinical and genetic risk factors for severe RSV disease, novel antivirals and the contribution of viral dynamics to the clinical phenotype of illness. He is also involved in studying better ways to prescribe and monitor antibiotics  for efficacy and safety. Other specific interests include quality improvement projects and medical education.

Clinical Interests:




Mass General for Children: Pediatric Infectious Disease & Immunodeficiencies Program
275 Cambridge St.
5th Floor
Boston, MA 02114
Phone: 617-726-8707

Medical Education

  • MD, American University of the Caribbean
  • Residency, American University - Beirut, Faculty of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, St. Jude's Children's Research Hospital

American Board Certifications

  • Pediatric Hospital Medicine, American Board of Pediatrics
  • Pediatric Infectious Disease, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


2002- present Clinical and bench research on the Respiratory Syncytial Virus (RSV).

  • Surfactant protein A Genetic Polymorphism and its effects on RSV disease. Viral quantification by standard methods, Real time PCR and cloning techniques (Basic science and clinical research).
  • RSV disease in immunocompromised cancer patients (Clinical research)
  • Examination of the immune response following infection with RSV

2012- present:

  • Evaluating novel methodologies for prescribing antibiotics
  • Studying the pharmacokinetics of novel antibiotics in phases 1 and 2


    1. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory Syncytial Virus load predicts disease severity in previously healthy infants. JID. 2005 Jun 1;191(11):1861-1868.
    2. El Saleeby CM, Somes GW, DeVincenzo JP, Gaur AH. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics. 2008 Feb;121(2):235-243.
    3. El Saleeby CM, Li R, Somes GW, Dahmer MK, Quasney MW, DeVincenzo JP. The Association of Surfactant Protein A (SPA) polymorphisms and disease severity within an RSV infected population. J Pediatr. 2010 Mar;156(3):409-414.
    4. El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, DeVincenzo JP. Respiratory syncytial virus load, viral dynamics and disease severity in previously healthy naturally infected children. JID. 2011 Oct;204(7):996-1002.
    5. Cummings BM, Cowl AS, Yager PH, Saleeby CM, Shank ES, Noviski N. Cardiovascular Effects of Continuous Dexmedetomidine Infusion Without a Loading Dose in the Pediatric Intensive Care Unit. J Intensive Care Med. 2014 Jun 12.
    6. Palakshappa D, Carter LP, El Saleeby CM. Discrepancies in After-Hours Communication Attitudes between Pediatric Residents and Supervising Physicians. J Pediatr. 2015 Dec;167(6):1429-35.
    7. Miloslavsky M, Galler MF, Moawad I, Actis J, Cummings BM, El Saleeby CM. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative. Pediatrics. 2017 Jun;139(6).
    8. Boadu O, Gombolay GY, Caviness V, El Saleeby CM. Intoxication from Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead. Pediatric Emergency Care. Manuscript # PCARE-D-17-00151R1. Accepted for publication on 12/07/2017.

Reviews: Comments and Ratings